Literature DB >> 3341578

Testing computer-controlled infusion pumps by simulation.

S L Shafer1, L C Siegel, J E Cooke, J C Scott.   

Abstract

The pharmacokinetic behavior of intravenous anesthetic drugs can be described by two- or three-compartment models. Rapid achievement and maintenance of steady plasma concentrations of these drugs requires a complicated delivery scheme, perhaps best controlled by a computer. The authors developed a method of simulating the performance of a computer-controlled infusion pump from the differential equations describing drug transfer between compartments. They also derived a mathematically simple and flexible approximate solution to these equations using Euler's numerical method. They incorporated this approximate solution into a computer-controlled infusion pump for intravenous drugs. They tested their pump by simulating the administration of fentanyl to a hypothetical patient whose fentanyl pharmacokinetics were described by a three-compartment model. The exact analytical solution served as the standard of comparison. The approximation technique, using a 15-s interval between model updates, had a maximum error of 0.35 ng.ml-1, and rapidly converged on the exact solution. The simulations revealed oscillations in the system. The authors suggest that such simulations be used to evaluate computer-controlled infusion pumps prior to clinical trials of these devices.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3341578     DOI: 10.1097/00000542-198802000-00013

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  21 in total

1.  Blood-brain barrier transport and brain distribution of morphine-6-glucuronide in relation to the antinociceptive effect in rats--pharmacokinetic/pharmacodynamic modelling.

Authors:  M R Bouw; R Xie; K Tunblad; M Hammarlund-Udenaes
Journal:  Br J Pharmacol       Date:  2001-12       Impact factor: 8.739

2.  Nonlinear model-based predictive control of non-depolarizing muscle relaxants using neural networks.

Authors:  M Lendl; U H Schwarz; H J Romeiser; R Unbehauen; M Georgieff; G F Geldner
Journal:  J Clin Monit Comput       Date:  1999-07       Impact factor: 2.502

Review 3.  [Modern concepts in pharmacokinetics of intravenous anesthetics].

Authors:  T Heidegger; C F Minto; T W Schnider
Journal:  Anaesthesist       Date:  2004-01       Impact factor: 1.041

Review 4.  Target-controlled infusion systems: role in anaesthesia and analgesia.

Authors:  M C van den Nieuwenhuyzen; F H Engbers; J Vuyk; A G Burm
Journal:  Clin Pharmacokinet       Date:  2000-02       Impact factor: 6.447

5.  Measuring the predictive performance of computer-controlled infusion pumps.

Authors:  J R Varvel; D L Donoho; S L Shafer
Journal:  J Pharmacokinet Biopharm       Date:  1992-02

6.  Estimation of cardiac output in a pharmacological trial using a simple method based on arterial blood pressure signal waveform: a comparison with pulmonary thermodilution and echocardiographic methods.

Authors:  Jani Penttilä; Amir Snapir; Erkki Kentala; Juha Koskenvuo; Jussi Posti; Mika Scheinin; Harry Scheinin; Tom Kuusela
Journal:  Eur J Clin Pharmacol       Date:  2006-03-29       Impact factor: 2.953

Review 7.  Pharmacokinetic-pharmacodynamic modelling: history and perspectives.

Authors:  Chantal Csajka; Davide Verotta
Journal:  J Pharmacokinet Pharmacodyn       Date:  2006-01-11       Impact factor: 2.745

8.  Estimating the rate of thiopental blood-brain equilibration using pseudo steady state serum concentrations.

Authors:  P O Maitre; M Bührer; S L Shafer; D R Stanski
Journal:  J Pharmacokinet Biopharm       Date:  1990-06

9.  Blood-brain barrier equilibration of codeine in rats studied with microdialysis.

Authors:  R Xie; M Hammarlund-Udenaes
Journal:  Pharm Res       Date:  1998-04       Impact factor: 4.200

10.  Morphine blood-brain barrier transport is influenced by probenecid co-administration.

Authors:  Karin Tunblad; E Niclas Jonsson; Margareta Hammarlund-Udenaes
Journal:  Pharm Res       Date:  2003-04       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.